Finally, we confirmed overexpression of P53 protein in the ALK/TP53 co-mutated lung cancer sample (case 4) compared to the only ALK-rearranged cases by immunohistochemistry, and the latter expressed only a small amount of wild-type P53 protein (Figure S1). This evidence concerns the gene ALK and lung carcinoma.